Format

Send to:

Choose Destination
See comment in PubMed Commons below
Iran Red Crescent Med J. 2013 Jun;15(6):515-8. doi: 10.5812/ircmj.10232. Epub 2013 Jun 5.

Accuracy of estrogen and progesterone receptor assessment in core needle biopsy specimens of breast cancer.

Author information

  • 1Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, IR Iran ; Department of Surgery, Cancer Institute, Tehran University of Medical Sciences, Tehran, IR Iran.
  • 2Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, IR Iran ; Department of Surgery, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, IR Iran.
  • 3Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, IR Iran.
  • 4Department of Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran IR Iran.
  • 5Department of Immunohistochemistry, Cancer Institute, Tehran University of Medical Sciences, Tehran, IR Iran.
  • 6Breast Clinic Cancer Institute, Tehran University of Medical Sciences, Tehran, IR Iran.

Abstract

BACKGROUND:

Diagnosis of breast cancer is completed through core needle biopsy (CNB) of the tumors but there is controversy on the accuracy of hormone receptor results on CNB specimens.

OBJECTIVES:

We undertook this study to compare the results of hormone receptor assessment in CNB and surgical samples on our patients.

PATIENTS AND METHODS:

Hormone receptor status was determined in CNB and surgical samples in breast cancer patients whose CNB and operation had been performed in this institute from 2009 to 2011 and had not undergone neoadjuvant chemotherapy.

RESULTS:

About 350 patients, 60 cases met all the criteria for entering the study. The mean age was 49.8 years. Considering a confidence interval (CI) of 95%, the sensitivity of ER and PR assessment in CNB was 92.9% and 81%, respectively and the specificity of both was 100%. The Accuracy of CNB was 98% for ER and 93% for PR.

CONCLUSIONS:

Our results confirm the acceptable accuracy of ER assessment on CNB. The subject needs further investigation in developing countries where omission of the test in surgical samples can be cost and time-saving.

KEYWORDS:

Breast; Carcinoma; Estrogen; Neoplasm; Progesterone

PMID:
24349751
[PubMed]
PMCID:
PMC3840840
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk